[English] 日本語
Yorodumi- EMDB-42524: Cryo-EM Structure of Full-Length Spike Protein of Omicron XBB.1.5 -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-42524 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Cryo-EM Structure of Full-Length Spike Protein of Omicron XBB.1.5 | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | SARS-CoV2 / Spike Protein / Omicron / XBB.1.5 / VIRAL PROTEIN | |||||||||
Function / homology | Function and homology information Maturation of spike protein / viral translation / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / entry receptor-mediated virion attachment to host cell ...Maturation of spike protein / viral translation / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / entry receptor-mediated virion attachment to host cell / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / membrane fusion / Attachment and Entry / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / endocytosis involved in viral entry into host cell / receptor ligand activity / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / identical protein binding / membrane / plasma membrane Similarity search - Function | |||||||||
Biological species | Severe acute respiratory syndrome coronavirus 2 | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 2.98 Å | |||||||||
Authors | Huynh KW / Chang JS / Fennell KF / Che Y / Wu H | |||||||||
Funding support | 1 items
| |||||||||
Citation | Journal: NPJ Vaccines / Year: 2024 Title: Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine. Authors: Kayvon Modjarrad / Ye Che / Wei Chen / Huixian Wu / Carla I Cadima / Alexander Muik / Mohan S Maddur / Kristin R Tompkins / Lyndsey T Martinez / Hui Cai / Minah Ramos / Sonia Mensah / ...Authors: Kayvon Modjarrad / Ye Che / Wei Chen / Huixian Wu / Carla I Cadima / Alexander Muik / Mohan S Maddur / Kristin R Tompkins / Lyndsey T Martinez / Hui Cai / Minah Ramos / Sonia Mensah / Brittney Cumbia / Larissa Falcao / Andrew P McKeen / Jeanne S Chang / Kimberly F Fennell / Kevin W Huynh / Thomas J McLellan / Parag V Sahasrabudhe / Wei Chen / Michael Cerswell / Miguel A Garcia / Shilong Li / Rahul Sharma / Weiqiang Li / Kristianne P Dizon / Stacy Duarte / Frank Gillett / Rachel Smith / Deanne M Illenberger / Kari Sweeney Efferen / Annette B Vogel / Annaliesa S Anderson / Uğur Şahin / Kena A Swanson / Abstract: As SARS-CoV-2 evolves, increasing in potential for greater transmissibility and immune escape, updated vaccines are needed to boost adaptive immunity to protect against COVID-19 caused by circulating ...As SARS-CoV-2 evolves, increasing in potential for greater transmissibility and immune escape, updated vaccines are needed to boost adaptive immunity to protect against COVID-19 caused by circulating strains. Here, we report features of the monovalent Omicron XBB.1.5-adapted BNT162b2 vaccine, which contains XBB.1.5-specific sequence changes, relative to the original BNT162b2 backbone, in the encoded prefusion-stabilized SARS-CoV-2 spike protein (S(P2)). Biophysical characterization of Omicron XBB.1.5 S(P2) demonstrated that it maintains a prefusion conformation and adopts a flexible, predominantly open, state, with high affinity for the human ACE-2 receptor. When administered as a 4th dose in BNT162b2-experienced mice, the monovalent Omicron XBB.1.5 vaccine elicited substantially higher serum neutralizing titers against pseudotyped viruses of Omicron XBB.1.5, XBB.1.16, XBB.1.16.1, XBB.2.3, EG.5.1 and HV.1 sublineages and phylogenetically distant BA.2.86 lineage than the bivalent Wild Type + Omicron BA.4/5 vaccine. Similar trends were observed against Omicron XBB sublineage pseudoviruses when the vaccine was administered as a 2-dose series in naive mice. Strong S-specific Th1 CD4 and IFNγ CD8 T cell responses were also observed. These findings, together with real world performance of the XBB.1.5-adapted vaccine, suggest that preclinical data for the monovalent Omicron XBB.1.5-adapted BNT162b2 was predictive of protective immunity against dominant SARS-CoV-2 strains. | |||||||||
History |
|
-Structure visualization
Supplemental images |
---|
-Downloads & links
-EMDB archive
Map data | emd_42524.map.gz | 567.8 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-42524-v30.xml emd-42524.xml | 19.2 KB 19.2 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_42524_fsc.xml | 17.8 KB | Display | FSC data file |
Images | emd_42524.png | 159.5 KB | ||
Filedesc metadata | emd-42524.cif.gz | 7.1 KB | ||
Others | emd_42524_half_map_1.map.gz emd_42524_half_map_2.map.gz | 556.7 MB 556.8 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-42524 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-42524 | HTTPS FTP |
-Validation report
Summary document | emd_42524_validation.pdf.gz | 1.1 MB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_42524_full_validation.pdf.gz | 1.1 MB | Display | |
Data in XML | emd_42524_validation.xml.gz | 26.1 KB | Display | |
Data in CIF | emd_42524_validation.cif.gz | 34.6 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-42524 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-42524 | HTTPS FTP |
-Related structure data
Related structure data | 8uszMC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data | Similarity search - Function & homologyF&H Search |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_42524.map.gz / Format: CCP4 / Size: 600.7 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.75 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: Half Map A
File | emd_42524_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half Map A | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Half Map B
File | emd_42524_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half Map B | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
-Entire : SAR-CoV-2 Spike Protein Omicron XBB.1.5 Variant
Entire | Name: SAR-CoV-2 Spike Protein Omicron XBB.1.5 Variant |
---|---|
Components |
|
-Supramolecule #1: SAR-CoV-2 Spike Protein Omicron XBB.1.5 Variant
Supramolecule | Name: SAR-CoV-2 Spike Protein Omicron XBB.1.5 Variant / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus 2 |
Molecular weight | Theoretical: 428 KDa |
-Macromolecule #1: Spike glycoprotein
Macromolecule | Name: Spike glycoprotein / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus 2 |
Molecular weight | Theoretical: 142.729594 KDa |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: VNLITRTQSY TNSFTRGVYY PDKVFRSSVL HSTQDLFLPF FSNVTWFHAI HVSGTNGTKR FDNPALPFND GVYFASTEKS NIIRGWIFG TTLDSKTQSL LIVNNATNVV IKVCEFQFCN DPFLDVYQKN NKSWMESEFR VYSSANNCTF EYVSQPFLMD L EGKEGNFK ...String: VNLITRTQSY TNSFTRGVYY PDKVFRSSVL HSTQDLFLPF FSNVTWFHAI HVSGTNGTKR FDNPALPFND GVYFASTEKS NIIRGWIFG TTLDSKTQSL LIVNNATNVV IKVCEFQFCN DPFLDVYQKN NKSWMESEFR VYSSANNCTF EYVSQPFLMD L EGKEGNFK NLREFVFKNI DGYFKIYSKH TPINLERDLP QGFSALEPLV DLPIGINITR FQTLLALHRS YLTPVDSSSG WT AGAAAYY VGYLQPRTFL LKYNENGTIT DAVDCALDPL SETKCTLKSF TVEKGIYQTS NFRVQPTESI VRFPNITNLC PFH EVFNAT TFASVYAWNR KRISNCVADY SVIYNFAPFF AFKCYGVSPT KLNDLCFTNV YADSFVIRGN EVSQIAPGQT GNIA DYNYK LPDDFTGCVI AWNSNKLDSK PSGNYNYLYR LFRKSKLKPF ERDISTEIYQ AGNKPCNGVA GPNCYSPLQS YGFRP TYGV GHQPYRVVVL SFELLHAPAT VCGPKKSTNL VKNKCVNFNF NGLTGTGVLT ESNKKFLPFQ QFGRDIADTT DAVRDP QTL EILDITPCSF GGVSVITPGT NTSNQVAVLY QGVNCTEVPV AIHADQLTPT WRVYSTGSNV FQTRAGCLIG AEYVNNS YE CDIPIGAGIC ASYQTQTKSH RRARSVASQS IIAYTMSLGA ENSVAYSNNS IAIPTNFTIS VTTEILPVSM TKTSVDCT M YICGDSTECS NLLLQYGSFC TQLKRALTGI AVEQDKNTQE VFAQVKQIYK TPPIKYFGGF NFSQILPDPS KPSKRSFIE DLLFNKVTLA DAGFIKQYGD CLGDIAARDL ICAQKFNGLT VLPPLLTDEM IAQYTSALLA GTITSGWTFG AGAALQIPFA MQMAYRFNG IGVTQNVLYE NQKLIANQFN SAIGKIQDSL SSTASALGKL QDVVNHNAQA LNTLVKQLSS KFGAISSVLN D ILSRLDPP EAEVQIDRLI TGRLQSLQTY VTQQLIRAAE IRASANLAAT KMSECVLGQS KRVDFCGKGY HLMSFPQSAP HG VVFLHVT YVPAQEKNFT TAPAICHDGK AHFPREGVFV SNGTHWFVTQ RNFYEPQIIT TDNTFVSGNC DVVIGIVNNT VYD PLQPEL DSFKEELDKY FKNHTSPDVD LGDISGINAS VVNIQKEIDR LNEVAKNLNE SLIDLQELGK YEQYIKWPWY IWLG FIAGL IAIVMVTIML CCMTSCCSCL KGCCSCGSCC KFDEDDSEPV LKGVKLHYTG GGGSGGGGSW SHPQFEKGGG GSGGG GSWS HPQFEK UniProtKB: Spike glycoprotein |
-Macromolecule #3: 2-acetamido-2-deoxy-beta-D-glucopyranose
Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 3 / Number of copies: 19 / Formula: NAG |
---|---|
Molecular weight | Theoretical: 221.208 Da |
Chemical component information | ChemComp-NAG: |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Concentration | 5.0 mg/mL | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
Details: 25mM Tris (pH 7.5), 150mM NaCl, 1.0mM EDTA, 0.02% DDM | |||||||||||||||
Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 200 | |||||||||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Instrument: FEI VITROBOT MARK IV |
-Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Number grids imaged: 1 / Number real images: 6700 / Average exposure time: 2.05 sec. / Average electron dose: 40.0 e/Å2 Details: Selectris Energy Filter was also used during data collection. |
Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.6 µm / Nominal defocus min: 0.8 µm |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |